Home › Breast Cancer › NCT07207564
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
RecruitingObservational studyHealthy volunteers welcome
Who can join
Ages 18 to 100 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Female patients, ages 18 to 100 years * Had a benign breast biopsy at Mayo Clinic between 2002-2022 Exclusion Criteria: * All male patients * Prior or concomitant diagnosis of BC * Diagnosis of BC within six months of benign breast disease * Denial of research authorization * Concurrent or post-biopsy bilateral prophylactic mastectomy
About the study
The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.
What is being tested
- Non-Interventional Study (other)
Sponsor: Mayo Clinic · Participants: 4,500 · Started: Aug 28, 2025
Contact the study team
- Laura Pacheco-Spann · Phone: 904-953-0408
- Clinical Trials Referral Office · Phone: 855-776-0015
Official record on ClinicalTrials.gov — NCT07207564
Locations in the U.S.
| Florida | Mayo Clinic in Florida, Jacksonville |
| Minnesota | Mayo Clinic in Rochester, Rochester |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.